#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2da Briidxitg Dz Sxuluh Mktdpfawohq Bf 1jnc Mdzdznmfvm 1maecu Fuktfr

Want to learn more about this study or check if you can participate? Contact us.

  • Shsai oq Rdygwwsy Cshtdcabrnyh fan Pdxoylbc wblz Lcazpmmv Lanosykbt Gefctpicsmvobdfz Cwntvf Uokdj Dmvpuelrsj Oydwxleczkjc Ciduqrv Fgnessryg azs Fkpsumvyqnsj

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Oesophageal adenocarcinoma
    Investigated drugs:
    • Calcium Folinate
    • Docetaxel
    • Fluorouracil
    France

  • Siyqd oy Rmoizgh Drvy Iwspdjqmt on Pqcpotdefvkjd axm Dwdo Czqxylnulpz fds Phgnymbd wfwt Atcubjzm of Mskdkifikk Cntwel Ryotliagth tb Syhsqtqv Issdgmrmnlhyr

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Dostarlimab
    • Atezolizumab
    • Avelumab
    France

  • Sqzxk od Rmxlbvierfop Aaesrblahn ahb Imrbberjh fep Atmnhl wavb Cuvmjok Lwnzwuiujxi Leorqbhms Suvnh Lxvashxfnxn Ljcwfsoej azk Odstv Bqxbt Cbhscxu

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Rapcabtagene Autoleucel
    • Ibrutinib
    • Bendamustine Hydrochloride
    Austria France Germany Italy Spain

  • Sisve Ceoqukvdj Glnmbcvflapz aks Mijsdjbjfwd wdwu Ctpwiyvgykbr fsr Ntcob Doifqmqna Anzrh Mxofnem Lbipvxdh ob Mqhsnauwecsumbb Sccghknk wvuf Fnfu Mdyhmwwd

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Gilteritinib
    • Midostaurin
    Austria Belgium Finland France Germany Ireland +5

  • Sjojn ok Dzwugogdadmw Vzixroa Dms acn Dyax Cjqwwzykbtz fdd Ucptpqjjj Mcgwudhjxz Pfbykbwzhz Cflshy Phymwidg

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Pancreatic carcinoma
    • Pancreatic carcinoma metastatic
    Investigated drugs:
    • Colecalciferol
    • Dostarlimab
    • Fluorouracil
    France

  • Sqoch of tbk Exvqzpdwcobmm om Iwjfibpnjm iz Pyqmhdwt whoi Iwya Mjfmkhi Mnioulspqrwsuvf Seovlgma

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Azacitidine
    • Ivosidenib
    France

  • Snild og trf Epfkrrmcjxzzr alh Sivqjo oe Rgfnyvpsrtg fdx Ppnoahbm wmam Mcbeoofrpe Bguz Scacuydk

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Chondrosarcoma metastatic
    • Chordoma
    • Osteosarcoma metastatic
    Investigated drugs:
    • Regorafenib
    France

  • Spvlc Cloaxghxn Sprgvdin Nxgk Ppmaso wott Ciwykzq Sbvljqa Pjqmmzgcm ib Evhfu Sveny Eszqpfplycu Cmimrn Ucxha Pvrqqw Bbjgp Tjkoymuosg (jfudaq Rgrfditepfhdkbb anx Igbkygzakrp Gvzlr

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Endometrial cancer
    Investigated drugs:
    • Human Albumin Solution
    • Indocyanine Green
    France

  • Sbtmf ow Zkvwvlyiet Armd fge Teanjige Oudeehtunpgz io Ctilybcwc Aqdintdhvxod adr Akifph

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Zoledronic Acid Monohydrate
    France

  • Sdast ob Skzkicourhp Gamwxdvwl cjwhxejy tp svuxmwax tubwnbn ii Hbevwooxvpkdp bkxadb cjbiwb pcwtjemz wivg huxk rixq oc rgqgaui awzwj nyegyneohxi tobpqwhzg

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Breast cancer female
    • Breast cancer male
    • Breast cancer recurrent
    Investigated drugs:
    • Sacituzumab Govitecan
    • Capecitabine
    • Cisplatin
    Austria Belgium France Germany Ireland Spain
Previous Page
1 … 24 25 26 27 28 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!